Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies
Article in Crohn's & Colitis 360 (October 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Crohn's & Colitis 360 (October 2023)
Article in Inflammatory Bowel Diseases (August 2023)
Article in Future Science OA (June 2023)